Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-16

Clinical Trial Update: Evaluation of Deep Brain Stimulation (DBS) of the Right Operculum 3 (OP3) in Permanent Non-pulsatile Disabling Tinnitus (TINNOP3-DBS) [NA]

View source ↗

Summary

The trial evaluates deep brain stimulation of the right operculum (OP3) for permanent non-pulsatile disabling tinnitus and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deep Brain Stimulation (DBS) of the Right Operculum 3 (OP3)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Severe Permanent Uni or Bilateral Non-pulsatile Tinnitus, Without Associated Vestibular Pathology | NA | Status: RECRUITING